DOI QR코드

DOI QR Code

Synthesis and antibacterial screening of N-[coumarin-6-yl] spiro-indoloazetidin-2-ones/thiazolidin-4-ones

N-[coumarin-6-yl] spiro-indoloazetidin-2-ones/thiazolidin-4-ones의 합성과 항균검사

  • Mulwad, V. V. (The Institute of Science, Department of Chemistry) ;
  • Mir, Abid Ali (The Institute of Science, Department of Chemistry)
  • Published : 2008.12.20

Abstract

Keywords

6-Amino-coumarin ; Spiro Compound ; Thiazolidin ; Azetidine ; Biological Activity

INTRODUCTION

Coumarins are nowadays an important group of organic compounds that are used as bactericides1, fungicides,2 anti-inflammatory,3 and antitumour agents.4,5 These pharmacological properties of coumarins aroused our interest in synthesizing several new compounds featuring different heterocyclic rings fused onto the coumarin moiety with the aim of obtaining more potent pharmacologically active compounds. Various indole derivatives show a wide range of biochemical properties.6 It has been reported that if the indole7 ring is joined to other heterocyclic compounds through a spiro-carbon atom, the resulting compounds show increased spectrum of biological activities.8-16 Spiro nuclei have also drawn considerable attention of the chemist because of their antiseptic,17 analgesic18 and broad-spectrum antimicrobial activities.19 Hence, introduction of spiro nucleus to such vital molecules will enhance their biological activity.20

By observing the importance of the above heterocycles, we planned to synthesize spiro-indolothiazolidin- 4-one and spiro-indoloazetidin-2-ones ring system from 6-aminocoumarin as starting materials which may possess some of the above biological activity.

 

RESULTS AND DISCUSSION

Ethyl-N-(coumarin-6-yl)carbamate was obtained by refluxing 6-aminocoumarin with chloroethylformate in presence of triethyl amine to afford compound 1a-c which was subsequently converted into its acid hydrazide 2a-c.The IR spectrum of 1c in KBr showed band at 1730 cm-1 for coumarin stretching and at 1720 cm-1 for carbonyl stretching of -NH-C=O. In its 1H NMR it shows signals as triplet for CH3 protons at δ 1.40 and as a quartet at δ 4.35 for methylene protons and a peak at δ 8.30 for -NH group which is D2O exchangeable. IR spectrum in KBr of compound 2c showed band at 3100-3300 cm-1 for -NH stretching. The 1H NMR showed absence of signals for methyl protons and methylene protons which were observed in compound 1a-c as a triplet and quartet indicating the formation of its acid hydrazide.

Compound 2a-c was treated with isatin in ethanol to give indole-2-oxo-3-(2/-oxo-2/H-benzopyran-6/-yl-semicarbazone 3a-c.The IR spectrum of compound 3c in KBr showed bands at 3456cm-1 for -NH stretching, at 2950 cm-1 for -CH aromatics stretching, at 1723 cm-1 for carbonyl carbon. 1H NMR spectrum in CDCl3 shows peak at 12.5 ppm for -NH of indole nucleus which is D2O exchangeable, along with other peaks. Compound 3a-c separately on refluxing with thiaglycollic acid in dry 1,4-dioxane and with chloroacetylchloride gave 3-(2/-oxo-2/H-benzopyran-6/-yl)-spiro-3H-[indole-(1H,2H)-3,2-(4H)-thiazolidin-1-yl]-2,4-dioxo-urea 4a-c, and 3-(2/-oxo-2/H-benzopyran-6/-yl)-spiro-3H-[indole-(1H,2H)-3-chloro-2,4-dioxo-azetidin-1-yl]-urea 5a-c respectively. The IR spectrum of compound 4c in KBr showed bands at 3430cm-1 for -NH groups, at 1721 cm-1 for carbonyl group. 1H NMR in CDCl3 showed a singlet at 4.10 for two protons of -S-CH2 , a singlet at 12.5 for one proton of -NH which is D2O exchangeable. In its 13C NMR, showed signals at 45.6 for spiro-carbon atom, and at 159.6 for carbonyl of coumarin, at 175.5 for carbonyl of indole nucleus and at 182.3 for carbonyl of thiazolidinone ring, etc. Similarly compound 5c showed a band at 3450 cm-1 for -NH group in its IR spectrum. 1H NMR in CDCl3 showed a singlet at 6.23 ppm for one proton of C3-H and peak at 5.09 ppm for -CH-Cl. In its 13C NMR, it showed signals at 38.6 for spiro-carbon atom, a signal at 60.1 for CH-Cl, at 160.0 for carbonyl of Coumarin and at 174.6 for carbonyl of indole nucleus. The mass spectrum of compound 5c shows M+ at 452 and M+2 at 454 indicating the presence of chlorine atom. It also gives positive Beilstein and Lassignes sodium fusion tests, indicating the presence of halogen. The structures of all the compounds were in agreement with spectral and analytic data and all the synthesized compounds were screened in vitro for antibacterial activity(Scheme 1).

Scheme 1.

Biological Evaluation

In vitro anti-bacterial evaluation of newly synthesized compounds was done against four bacterial strains viz S. aureus, Bacillus subtilis, Pseudomonas aurignosa and Escherichia coli by cup plate method.21 The results indicated that compound 3a-c, 4a-c and 5a-c showed total inhibition of bacterial growth at 100 μgml-1 concentration. (Table 1). The zones of inhibition of norfloxacin was taken as 100% and the observed zones of inhibition of the newly synthesized compounds have been expressed as related to the standard. From the antibacterial screening of the compounds 3a-c, 4a-c and 5a-c it has been observed that presence of methyl group in coumarin ring increases the activity.22

Table 1.Std. Used- Norfloxacin, 100% inhibition at each concentration.

 

CONCLUSION

In conclusion we here report the synthesis of some novel spiro-azetidin and spiro thiazolidin derivatives of amino coumarin under milder operating conditions. Among the tested compounds compound 5c showed the maximum activity. Rest of the compounds shows moderate to good biological activity.

 

EXPERIMENTAL

Melting points were taken in open capillaries and were uncorrected. IR spectra (νmax in cm-1) were recorded on Perkin Elmer FTIR and NMR (1H and 13C) was recorded on Jeol 300 MHz using TMS as standard. Mass spectra (GC-MS) on a Shimadzu GC-MS QP-2010. All products are purified by recrystallisation.The reaction are followed up and purity of the products is carried out on pre-coated TLC plates (Silica gel 60 F254, Merck), visualizing the sports in ultraviolet light. Column chromatography is performed on Merck silica gel (60-120 mesh).All the compounds gave satisfactory elemental analysis.

General Method for the synthesis of Ethyl-N-[Coumarin-6-yl] carbamate 1a-c

To a solution solution 6-amino-coumarin (0.01mole) in DMF (60 mL), was added chloroethylformate (0.015 moles) and triethyl amine (TEA) (0.015 mole) under cold condition. After the addition reaction mixture was refluxed on oil bath for 10-12 hrs. and monitored by TLC, after the reaction is complete, reaction mixture was poured with stirring into ice/cold water containing HCl. The solid obtained was filtered washed with water and dried, then purified by column chromatography using Ethyl acetate-Hexane (2:8) as eluent to give desired product 1a-c

(1a): yield (62%); m.p 176-178 ℃; IR (KBr, cm-1): 3405(NH), 1730(COOEt), 1720(CO); 1H NMR (CDCl3): δ 1.30 (t, 3H, J = 4.20Hz, CH2-CH3), 4.26 (q, 2H, J = 6.60Hz, CH2-CH3), 6.37(d, 1H, J = 9Hz, C3-H), 7.21(d, 1H, J = 9Hz, C8-H), 7.23(d, 1H, J = 9Hz, C7-H), 7.29(s, 1H, C5-H), 7.75(d, 1H, J = 9Hz, C4-H), 8.28(s, 1H, NH). Elemental analysis [Cal. (Obs.)]: C; 61.80% (61.71%), H; 4.75% (4.71%), N; 6.01% (6.09%).

(1b): yield (58%); m.p 192-194 ℃; IR (KBr, cm-1): 3435 (NH), 1735(COOEt), 1725(CO); 1H NMR (CDCl3): δ 1.35 (t, 3H, J = 4.20Hz, CH2-CH3), 2.25 (s, 3H, CH3), 4.30 (q, 2H, J = 6.60Hz, CH2-CH3), 6.26 (d, 1H, J = 9Hz, C3-H), 7.15 (s, 1H, C8-H), 7.30(s, 1H, C5-H), 7.72(d, 1H, J = 9Hz, C4-H), 8.32 (s, 1H, NH, D2O-exchangable); Elemental analysis [Cal. (Obs.)]: C; 63.15% (63.01%), H; 5.30% (5.27%), N; 5.66% (5.59%).

(1c): yield (55%); m.p 185-187 ℃; IR (KBr, cm-1): 3450 (NH), 2950 (CH-arom.), 1723 (>CO), 1730 (COOEt); 1H NMR (CDCl3): δ 1.40 (t, 3H, J = 4.20Hz, CH2-CH3), 2.30 (s, 3H, CH3), 2.40 (s, 3H, CH3), 4.35 (q, 2H, J = 6.60Hz, CH2-CH3), 6.23 (s, 1H, C3-H), 7.10 (s, 1H, C8-H.), 7.25 (s,1H, C5-H), 8.30(s, 1H, NH, D2O-exchangable); Elemental analysis [Cal. (Obs.)]: C; 64.36% (64.15%), H; 5.79% (5.76%), N; 5.36% (5.29%); MS, m/z (%): M+ 261(100), 233(20), 216(30), 188(25), 160(65), 77(20).

General procedure for N-[Coumarin-6-yl-]carbamic acid hydrazide 2a-c

Compound 1a-c (0.01) mole and hydrazine hydrate (99.9%) 0.04 mole were refluxed in ethanol for 10 hrs. after the completion of the reaction, excess of ethanol was distilled off and the solid compound was well washed with water and recrystallized from ethanol.

(2a): yield; (68%); m.p 196 ℃; IR (KBr, cm-1): 3384 (NH),1719 (CO), 1645 (NHCO); 1H NMR (CDCl3): δ 3.45 (s, 2H, NH2, D2O-exchangable), 4.15 (s, 1H, NH, D2O-exchangable), 6.26(d, 1H, J = 9Hz, C3-H), 7.21(d, 1H, J = 9Hz, C8-H), 7.30(d, 1H, J = 9Hz, C7-H), 7.39(s, 1H, C5-H), 7.78(d, 1H, J = 9Hz, C4-H), 8.30(s, 1H, NH); Elemental analysis [Cal. (Obs.)]: C; 54.80% (54.63%), H; 4.14% (4.23%), N; 19.17% (19.27%).

(2b): yield; (62%); m.p 205 ℃; IR (KBr, cm-1): 3432 (NH),1725 (CO), 1635 (NHCO); 1H NMR (CDCl3): δ 2.42 (s, 3H, CH3), 3.55 (s, 2H, NH2, D2O-exchangable), 4.12 (s, 1H, NH, D2O-exchangable), 6.25(d, 1H, J = 9Hz, C3-H), 7.12(s, 1H, C8- H), 7.28(s, 1H, C5-H), 7.76(d, 1H, J = 9Hz, C4-H), 8.28 (s, 1H, NH, D2O-exchangable); Elemental analysis [Cal. (Obs.)]: C; 56.65% (56.47%), H; 4.75% (4.71%), N; 18.02% (17.97%).

(2c): Yield; (65%); m.p 200 ℃; IR (KBr, cm-1): 3500 (NH), 3100-3300 (NH2), 1720 (>CO), 1688 (NHCO); 1H NMR (CDCl3): δ 2.20 (s, 3H, CH3), 2.40 (s, 3H, CH3), 3.60 (s, 2H, NH2, D2O-exchangable), 4.15 (s, 1H, NH, D2O-exchangable), 6.20 (s, 1H, C3-H), 6.85 (s, 1H, C8-H), 7.20 (s, 1H, C5-H), 8.20 (s, 1H, NH, D2O exchangable); Elemental analysis [Cal. (Obs.)]: C; 58.29% (58.17%), H; 5.30% (5.24%), N; 16.99 (16.92%); MS, m/z (%): M+ 247(100), 216(30), 188(40), 160(25), 133(32).

General procedure for indole-2-oxo-3-(2/-oxo-2/H-benzopyran-6/-yl-semicarbazone 3a-c. To the suspension of coumarin-6-yl-carbamic acid hydrazide (0.01 mole) in ethanol (30 mL) was added isatin (0.01 mole) and catalytic amount of glacial acetic acid (3-4 drops) and the reaction mixture was refluxed on water bath for three hrs. The mixture was then cooled and poured into crushed ice the product separated was filtered, washed with water dried and recrystallized from ethanol.

(3a): yield, (70%); m.p 200-202 ℃; IR (KBr, cm-1): 3423 (NH), 2950 (CH-arom.), 1721 (>CO), 1670 (NHCO); 1H NMR (CDCl3): δ 6.23(d, 1H, J = 9Hz, C3-H), 7.25(d, 1H, J = 9Hz, C8-H), 7.32(d, 1H, J = 9Hz, C7-H), 7.50(s, 1H, C5-H), 7.70-7.75 (m, 4H, aromatic-H), 7.76(d, 1H, J = 9Hz, C4-H), 8.11(s, 1H, NH), 11.18(s, 1H, NH, D2O-exchangable), 12.23(s, 1H, NH-indole, D20-exchangable); Elemental analysis [Cal. (Obs.)]: C; 62.07% (62.17%), H; 3.47% (3.50%), N; 16.08% (16.18%).

(3b): yield, (68%); m.p 205-207 ℃; IR (KBr, cm-1): 3432 (NH), 2945 (CH-arom.), 1721 (>CO), 1675 (NHCO); 1H NMR (CDCl3): δ 2.26 (s, 3H, CH3), 6.24 (d, 1H, J = 9Hz, C3-H), 7.30(s, 1H, C8-H), 7.50(s, 1H, C5-H), 7.70-7.75 (m, 4H, aromatic-H), 7.80(d, 1H, J = 9Hz, C4-H), 8.15(s, 1H, NH), 11.20(s, 1H, NH, D2O-exchangable), 12.30(s,1H, NH-indole, D20-exchangable); Elemental analysis [Cal. (Obs.)]: C; 62.98% (62.79%), H; 3.89% (3.83%), N; 15.46% (15.51%).

(3c): yield, (65%); m.p 198-200 ℃; IR (KBr, cm-1): 3456 (NH), 2950 (CH-arom.), 1723 (coumarin), 1675 (NHCO); 1H NMR (CDCl3): δ 2.31(s, 3H, CH3), 2.50 (s, 3H, CH3), 6.21 (s, 1H, C3-H), 7.21 (s, 1H, C8-H), 7.60(s, 1H, C5-H), 7.65-7.85(m, 4H, aromatic-H), 8.20 (s, 1H, NH, D20-exchangable), 11.50 (s, 1H, NH, D20-exchangable), 12.50 (s, 1H, NH-indole, D20-exchangable); Elemental analysis [Cal. (Obs.)]: C; 63.83% (63.65%), H; 4.28% (4.33%), N; 14.89% (14.80%); MS, m/z (%): M+ 376(100), 231(25), 188(15), 145(5), 161(15), 133(20), 77(45).

General procedure for synthesis of 3-(2/-oxo-2/H-benzopyran-6/-yl)-spiro-3H-[indole-(1H, 2H)-3,2-(4H)-thiazolidin-1-yl]-2,4-dioxo-urea 4a-c

Compound 3a-c (0.01 mole) and thiaglycollic acid (0.01 mole) was refluxed in presence of catalytic amount of anhydrous ZnCl2 in dry 1, 4-dioxane (25 mL) for 6 hrs. After the completion of reaction, excess of I, 4 dioxane was evaporated under rotor evaporator to give solid, the solid obtained was filtered, washes with water and purified by recrystallization from methanol to give comp. 4a-c.

(4a): yield, (72%); m.p 225℃; IR (KBr, cm-1): 3433 (NH), 1725 (CO), 1640(NHCO); 1H NMR (CDCl3): δ 4.09(s, 2H, S-CH2), 6.25(d, 1H, J = 9Hz, C3-H), 7.30(d, 1H, J = 9Hz, C8-H), 7.33(d, 1H, J = 9Hz, C7-H), 7.50(m, 4H, aromatic-H), 7.65(s, 1H, C5-H), 7.72(d, 1H, J = 9Hz, C4-H), 8.18(s, 1H, NH, D2O exchangeable), 11.26 (s, 1H, NH, D2O exchangable), 12.32 (s, 1H, NH-indole, D2O exchangable); Elemental analysis [Cal. (Obs.)]: C; 56.87% (56.95%), H; 3.34% (3.27%), N; 13.26% (13.30%), S; 7.59% (7.66%).

(4b): yield, (68%); m.p 243-245℃; IR (KBr, cm-1): 3435 (NH), 1719 (CO), 1635(NHCO); 1H NMR (CDCl3): δ 2.40 (s, 3H, CH3), 4.12(s, 2H, S-CH2), 6.26(d, 1H, J = 9Hz, C3-H), 7.30(s, 1H, C8-H), 7.50(m, 4H, aromatic-H), 7.70(s, 1H, C5-H), 7.78(d, 1H, J = 9Hz, C4-H), 8.15(s, 1H, NH, D2O exchangeable), 11.30 (s, 1H, NH, D2O exchangable), 12.45 (s, 1H, NH-indole, D2O exchangable); 13C NMR (300 MHz, CDCl3): δ 18.0(CH3), 32.4(S-CH2), 44.2 (spiro-carbon), 111.5(C3), 114-145(8- aromatic carbons), 128.1(C4a), 151.0(C8a), 151.2(C4), 155.2 (NHCONH), 160.6(C2), 176.5(CO, indole), 180.3 (CO, thiazolidine); Elemental analysis [Cal. (Obs.)]: C; 57.79% (57.58%), H; 3.70% (3.65%), N; 12.84% (12.90%), S; 7.35% (7.41%).

(4c): yield, (76%); m.p 238 ℃; IR (KBr, cm-1): 3430 (NH), 2921 (CH-arom.), 1721 (>CO), 1689(carbonyl of amide), 1610, 1550, 1400; 1H NMR (CDCl3): δ 2.25 (s, 3H, CH3), 2.50 (s, 3H, CH3), 4.10(s, 2H, S-CH2), 6.23 (s, 1H, C3-H), 7.20-7.80 (m, 6H, arom-H), 8.10 (s, 1H, NH, D2O exchangeable), 11.50 (s, 1H, NH, D20-exchangable), 12.50 (s, 1H, NH-indole, D2O exchangeable); 13C NMR (300 MHz, CDCl3): δ 17.2(CH3), 19.6(CH3), 33.4(S-CH2), 45.6(spiro-carbon), 113.5(C3), 115-145(8-aromatic carbons), 126.1(C4a), 150.0(C8a), 153.2(C4), 156.2(NHCONH), 159.6(C2), 175.5(CO, indole), 182.3(CO, thiazolidine); Elemental analysis [Cal. (Obs.)]: C; 58.66% (58.51%), H; 4.03% (3.98%), N; 12.44% (12.39%), S; 7.12% (7.23%); MS, m/z (%): M+ 450(55), 421(30), 376(20), 215(100), 172(65), 145(15), 90(10).

General procedure for 3-(2/-oxo-2/H-benzopyran-6/-yl)-spiro-3H-[indole-(1H,2H)-3-chloro-2,4-dioxo-azetidin-1-yl]-urea 5a-c

To a solution of 4c (0.01 moles) in 1, 4 dioxane, chloroacetyl chloride (0.01 moles) and triethylamine (0.01 moles) was added drop wise with constant stirring. The reaction mixture was then refluxed on water bath and excess of dioxane was distilled out and resulting mixture was poured in ice cold HCl, filtered, dried and recrystallized from ethanol to give the desired product.

(5a): yield, (62%); m.p 228-230 ℃; IR (KBr, cm-1): 3425 (NH), 2935(CH-arom.), 1721 (>CO), 1610; 1H NMR (CDCl3): ä 5.10 (s,1H, CH-Cl), 6.23(d, 1H, J = 9Hz, C3-H), 7.28(d, 1H, J = 9Hz, C8-H), 7.35(d, 1H, J = 9Hz, C7-H), 7.50(m, 4H, aromatic-H), 7.73(s, 1H, C5-H), 7.71(d, 1H, J = 9Hz, C4-H), 8.28 (s, 1H, NH, D2O-exchangable), 11.26 (s, 1H, NH, D20-exchangable), 12.38 (s, 1H, NH-indole, D20-exchangable); Elemental analysis [Cal. (Obs.)]: C; 56.55% (56.62%), H; 3.08% (3.14%), N; 13.19% (13.23%).

(5b): yield, (60%); m.p 238-240 ℃; IR (KBr, cm-1): 3450 (NH), 2928(CH-arom.), 1723 (>CO), 1610, 1550; 1H NMR (CDCl3): δ 2.28 (s, 3H, CH3), 5.10 (s, 1H, CH-Cl), 6.26(d, 1H, J = 9Hz, C3-H), 7.30(s, 1H, C8-H), 7.55(m, 4H, aromatic-H), 7.71(s, 1H, C5-H), 7.74(d, 1H, J = 9Hz, C4-H), 8.35 (s, 1H, NH, D2O-exchangable), 11.32 (s, 1H, NH, D20-exchangable), 12.45 (s, 1H, NH-indole, D20-exchangable); 13C NMR (300 MHz, CDCl3): δ 19.2(CH3), 40.6 (spiro-carbon), 63.1(CHCl), 112.5(C3), 110.0-140.0 (8-aromatic-C), 125.3(C4a), 151.0(C8a), 155.0(C4), 155.0(NHCONH), 161.0(C2), 169.3(CO, ß-Lactam), 175.6(CO, indole); Elemental analysis [Cal. (Obs.)]: C; 57.48% (57.29%), H; 3.45% (3.42%), N; 12.77% (12.74%).

(5c): yield, (58%); m.p 230-235 ℃; IR (KBr, cm-1): 3450 (NH), 2930(CH-arom.), 1720 (>CO), 1610, 1550, 1400; 1H NMR (CDCl3): δ 2.30 (s, 3H, CH3), 2.40 (s, 3H, CH3), 5.09 (s, 1H, CH-Cl), 6.23 (s, 1H, C3-H), 7.20-7.80 (m, 6H, arom-H), 8.30 (s, 1H, NH, D20-exchangable), 11.30 (s, 1H, NH, D20-exchangable), 12.50 (s, 1H, NH-indole, D2O-exchangable); 13C NMR (300 MHz, CDCl3): δ 17.1(CH3), 18.8(CH3), 38.6(spiro-carbon), 60.1(CHCl), 111.5(C3) 110.0-140.0(8-aromatic-C), 125.3(C4a), 151.0(C8a), 154.0(C4), 157.0(NHCONH), 160.0(C2), 168.3(CO, ß-Lactam), 174.6(CO, indole). Elemental analysis [Cal. (Obs.)]: C; 58.35% (58.24%), H; 3.78% (3.76%), N; 12.37% (12.40%); MS, m/z (%): M+ 452(100), M+2 454(33), 376(70), 188(32), 160(25), 145(10), 132(15), 43(20).

In vitro anti-bacterial assay

Various coumarin derivatives synthesized during present investigation have been subjected for their antibacterial screening by cup plate method21 against four bacterial strains at two concentrations using DMF as solvent. Antibacterial activity of test compounds was evaluated against gram-positive S. aurea, Bacillus Subtilis and gram-negative P. aurignosa, E. coli bacterial strains using norfloxicin as standard by cup plate method. Dimethyl formamide was used as solvent control. The bacteria were sub-cultured in a medium containing peptone (0.5%), yeast extract (0.15%), sodium chloride (0.35%), potassium dihydrogen phosphate (0.13%) and potassium monohydrogen phosphate (0.13%). Nutrient agar which served as the basal medium was prepared by dissolving bacteriological peptone (0.6%), yeast (0.3%), beef extract (0.13%) and agar (2.1%) in distilled water. The solution was sterilized for 20 min at 15 lbs. pressure in an autoclave. The basal medium (25–30 ml) (with glucose solution to hasten the bacterial growth) with bacterial culture was poured in sterile petri dishes. After the solidification medium holes of 9 mm diameter were bored to form cups with the help of a sterile cork borer. To this cup 0.02 ml of the solution of the test compound was added by sterilized pipettes. The Petri dishes were kept in a cold room to facilitate the diffusion of the solvent for about 2 h. The plates were then incubated at 37 ℃ for 24 h. The extent of inhibition was measured by the width of the inhibition zone in mm. Minimum inhibitory concentration (MIC) of the test solution was determined by diluting the test solution of required concentration. The zones of inhibition of norfloxicin were taken as 100% and the observed zones of inhibition of newly synthesized compounds have been expressed as related to the standard.

References

  1. Honmantgad, S. S.; Kulkarni, M. V.; Patil, V. D. Ind. J. Chem. 1985, 24B, 459
  2. Mulwad, V.V.; Pawar, R. B.; Chaskar, A. C. J. Kor. Chem. Soc. 2008, 52, 3. 249 https://doi.org/10.5012/jkcs.2008.52.3.249
  3. Mulwad, V.V.; Shirodkar, J. M. J. Het. Chem. 2003, 40, 377 https://doi.org/10.1002/jhet.5570400231
  4. Choudhari, B. P.; Mulwad, V. V. Ind. J. Chem. 2006, 45B, 309
  5. Mulwad, V.V.; Mir, A. A. J. Chem. Res. 2008, May, 292
  6. Mulwad, V. V.; Satwe, D. S. Ind. J. Chem. 2004, 43B, 2727
  7. Lloyd, H. A.; Horning, E. C. J. Am. Chem. Soc. 1954, 76, 3651 https://doi.org/10.1021/ja01643a014
  8. Mulwad, V. V.; Patil, C. A. Ind. J. Chem. 2005, 44B, 2355 https://doi.org/10.1021/ja01643a014
  9. Biradar, J. S.; Manjunath, S. Y. Ind. J. Chem. 2004, 43B, 141
  10. Choudhari, B. P.; Mulwad, V. V. Ind. J. Het. Chem. 2003, 12, 197
  11. Mogilaiah, K.; Babu-Rao, K. Ind. J. Het. Chem. 1998, 37B, 894
  12. Mulwad, V. V.; Lohar, M. V. Ind. J. Het. Chem, 2002, 12, 57
  13. Hugo, W. B.; Russel, A. B. Pharmaceutical Microbiology, 4th edition, Blackwell Scientific Publications, London., 1987; p 265
  14. Choudhari, B. P.; Mulwad, V. V. Ind. J. Chem. 2005, 44B, 1074
  15. Suryavanshi, J. P.; Pia, N. R. Ind. J. Chem. 2006, 45B, 1227
  16. Chande, M. S.; Karnik, B. M. J. Ind. Chem. Soc. 1990, 67, 220
  17. Kobayashi, G.; Matsuda, Y. Jap. Pat. 1968, 803385 ; C.A : 1968, 104, 33976s
  18. Pandeya, S. N.; Sriram, D.; Nath, G. Pharm Acta Helv. 1999, 74, 11 https://doi.org/10.1016/S0031-6865(99)00010-2
  19. Pandeya, S. N.; Sriram, D.; Nath, G. Eur. J. Med. Chem. 2000, 35, 249 https://doi.org/10.1016/S0223-5234(00)00125-2
  20. Mulwad, V.V.; Chaskar, A. C.; Shirodkar, J. M. Ind. J. Chem. 2005, 44B, 1465
  21. Emmanuel-Giota, A. A.; Fylaktakidou, K. C.; Hadjipavlou-Litina, D. J.; Litinas, K. E.; Nicolaides, D. N. J. Het. Chem. 2001, 387, 17
  22. Nofal, Z. M.; El-Zahar, M. I.; Abd El-Karim, S. S. Molecules. 2000, 5, 99 https://doi.org/10.3390/50200099
  23. Kawashima, F.; Sata, M.; Nakashima, S.; Kaorusou, Y.; Noriguchi, I. J. Med. Chem. 1986, 29, 2284 https://doi.org/10.1021/jm00161a026
  24. Kumar, P.; Nath, C.; Bhargave, K. P.; Shanher, K. Ind. J. Chem. 1982, 21B, 1182
  25. Hiremath, S. P.; Ullagaddi, A.; Purohit, M. G. Ind. J. Chem. 1988, 27B 1102
  26. Joshi, K. C.; Dandia, A.; Bhagat, S. Ind. J. Chem. 1990, 29B, 766
  27. Mogilaiah, K.; Babu-Rao, R. Ind. J. Chem. 1998, 37B, 894
  28. Rajapadhye, M.; Popp, F. D. J. Het. Chem. 1984, 21, 289 https://doi.org/10.1002/jhet.5570210203
  29. Morley, J. E.; Farr, S. A.; Flood, J. F. Eur. J. Pharmacol. 1996, 305, 23 https://doi.org/10.1016/0014-2999(96)00162-8
  30. El-Sayed, A. M.; Abd-Allah, O. A. Phosphorus Sulfur Silicon. 2001, 170, 75 https://doi.org/10.1080/10426500108040586
  31. El-Agrody, A. M.; Abd, El-Latif.; El-Hady, N. A.; Fakery, A. Molecules. 2001, 6, 519 https://doi.org/10.3390/60600519
  32. Mahboobi, S.; Sellmer, A.; Eichhorn, E.; Beckers, F. Eur. J. Med. Chem. 2005, 40, 85 https://doi.org/10.1016/j.ejmech.2004.10.007
  33. Parrick, J.; Yahya, A.; Jin, Y. Tetrahedron Lett. 1984, 25, 3099 https://doi.org/10.1016/0040-4039(84)80017-9
  34. Bergman, J.; Stalhandske, C.; Vallberg, H. Acta. Chem. Scand. 1997, 51, 753 https://doi.org/10.3891/acta.chem.scand.51-0753
  35. Sridhar, S. K.; Saravanan, M.; Ramesh, A. Eur. J. Med. Chem. 2001, 36, 615 https://doi.org/10.1016/S0223-5234(01)01255-7
  36. Dox, A. W.; Voder, L. J. Am. Chem. Soc. 1921, 43, 677 https://doi.org/10.1021/ja01436a040
  37. Mulwad, V. V.; Satwe, D. S. Ind. J. Chem. 2004, 43B, 2727

Cited by

  1. An eco-compatible synthesis of novel spiro[acenaphthylene-1,2′[1,3]-thiazolidine]-2,4′(1H)-diones using thiamine hydrochloride as efficient catalyst in aqueous medium vol.43, pp.1, 2017, https://doi.org/10.1007/s11164-016-2604-x
  2. Synthesis of ?-lactams with ? electron-withdrawing substituents vol.68, pp.52, 2012, https://doi.org/10.1016/j.tet.2012.04.007
  3. Synthesis of Some New Thiazolidine Derivatives and Their Biological Significance vol.50, pp.3-4, 2011, https://doi.org/10.2478/v10161-011-0066-4
  4. Synthesis and pharmaceutical importance of 2-azetidinone derivatives of phenothiazine vol.124, pp.3, 2012, https://doi.org/10.1007/s12039-012-0257-x
  5. Recent Progress on Routes to Spirooxindole Systems Derived from Isatin vol.51, pp.3, 2014, https://doi.org/10.1002/jhet.1114
  6. Facile synthesis of new 1,2,3-benzotriazolo-2-oxo-azetidine analogues by microwave irradiation vol.4, pp.2, 2011, https://doi.org/10.1016/j.arabjc.2010.06.035
  7. Synthesis of new series of N-3-[-{2-(substituted phenyl-4-oxo-5-(substituted benzylidene)-1,3-thiazolidine}-carbamyl]-propyl-2-aminothiazole and their biological importance vol.123, pp.5, 2011, https://doi.org/10.1007/s12039-011-0123-2
  8. New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: Synthesis, in vivo antithrombotic evaluation and molecular docking vol.52, 2014, https://doi.org/10.1016/j.bioorg.2013.11.002
  9. Synthesis and biological evaluation of some novel thiazole compounds as potential anti-inflammatory agents vol.65, 2013, https://doi.org/10.1016/j.ejmech.2013.04.005
  10. Recent developments and biological activities of thiazolidinone derivatives: A review vol.20, pp.11, 2012, https://doi.org/10.1016/j.bmc.2012.03.069
  11. Isatins As Privileged Molecules in Design and Synthesis of Spiro-Fused Cyclic Frameworks vol.112, pp.11, 2012, https://doi.org/10.1021/cr300135y
  12. Metal- and nonmetal-catalyzed synthesis of five-membered S,N-heterocycles vol.39, pp.2, 2018, https://doi.org/10.1080/17415993.2017.1415338